Save time and get answers to complex questions with AI chat
Allergan's patent for latisse expired?Drug patent watch trametinib?Brenzavvy discontinuation?Campath litigation germany?Xiaflex market launch year?
See the DrugPatentWatch profile for Rezafungin
Currently, there isn’t a published price for rezafungin. It has not (as of mid-2024) been approved for marketing by the FDA, so there’s no official list price or payer price available yet. Once it’s approved and marketed, price will depend on the indication, dosing schedule, country, and payer contracts, and patient out-of-pocket costs will vary by insurance and formulary. If you want, I can help you estimate costs once approval happens by: - Specifying your country/region (US, EU, others) - Indicating whether you want list price, payer price, or patient out-of-pocket estimate - Comparing to prices of other echinocandins for context Would you like me to check current status in a specific market or help you set up a pricing estimation framework?